Search
Advertisement
Newsmakers: Sun Pharma withdraws suit, fresh I-T notice for Nokia and more

Newsmakers: Sun Pharma withdraws suit, fresh I-T notice for Nokia and more

Major business news of the day

BusinessToday.In
BusinessToday.In
  • Updated Oct 9, 2015, 6:51 PM IST
Newsmakers: Sun Pharma withdraws suit, fresh I-T notice for Nokia and more
1/4
Facebook 'Like' button gets more emotive
'Liking' on Facebook is about to get interesting with six new 'reaction' emoticons. The new "reactions" will let users express love, laughter, happiness, shock, sadness and anger. It works by hovering or long-pressing the Like button and selecting the relevant emoji that you want to put in your message.

Newsmakers: Sun Pharma withdraws suit, fresh I-T notice for Nokia and more
2/4
General Motors recalls SUVs over faulty windshield wipers
General Motors is telling owners of some SUVs not to use their windshield wipers because an electrical short could cause the wiper motor to catch fire. The company is recalling nearly 32,000 Buick Enclave, Chevrolet Traverse and GMC Acadia SUVs from the 2016 model to fix the problem. Only 6,400 were sold and the rest are being held at dealerships until they are repaired. Most are in North America.

Newsmakers: Sun Pharma withdraws suit, fresh I-T notice for Nokia and more
3/4
I-T department sends fresh tax notice to Nokia India
The Income Tax Department has sent fresh tax notice on Nokia India, said tax authorities. The Finnish telecom firm, however, wants the fresh demand to be included in the ongoing negotiations between India and Finland to resolve the Rs 2,000-crore tax dispute. "Fresh tax demands notice has been served to Nokia India for dispute relating to other assessment years, apart from the one being contested currently in ITAT," a senior Finance Ministry official said.
Newsmakers: Sun Pharma withdraws suit, fresh I-T notice for Nokia and more
4/4
Sun Pharma withdraws suit filed by Ranbaxy against USFDA
Drug firm Sun Pharmaceutical has withdrawn its appeal in the lawsuit filed by Ranbaxy against the US health regulator challenging FDA's decision to revoke approvals for generic versions of Nexium and Valcyte.
The company has withdrawn its appeal in the lawsuit filed by erstwhile Ranbaxy Laboratories Ltd in November 2014 in a US District Court against US Food and Drug Administration, Sun Pharma said in a regulatory filing.